KORU Medical Systems, Inc. (NASDAQ:KRMD) Short Interest Up 5.6% in March

KORU Medical Systems, Inc. (NASDAQ:KRMD) was the target of a large increase in short interest during the month of March. As of March 31st, there was short interest totalling 1,050,000 shares, an increase of 5.6% from the March 15th total of 994,500 shares. Based on an average daily volume of 95,500 shares, the short-interest ratio is presently 11.0 days.

KORU Medical Systems Price Performance

Shares of NASDAQ:KRMD opened at $2.12 on Thursday. The company has a market cap of $96.91 million, a price-to-earnings ratio of -7.31 and a beta of 0.53. The company has a debt-to-equity ratio of 0.02, a current ratio of 4.55 and a quick ratio of 3.77. The firm has a 50 day simple moving average of $2.19 and a 200 day simple moving average of $2.27. KORU Medical Systems has a one year low of $1.98 and a one year high of $4.48.

KORU Medical Systems (NASDAQ:KRMD) last issued its quarterly earnings data on Wednesday, March 13th. The company reported ($0.02) EPS for the quarter, beating the consensus estimate of ($0.04) by $0.02. The business had revenue of $7.19 million during the quarter, compared to the consensus estimate of $7.01 million. KORU Medical Systems had a negative net margin of 48.18% and a negative return on equity of 27.82%. Research analysts predict that KORU Medical Systems will post -0.15 earnings per share for the current fiscal year.

Hedge Funds Weigh In On KORU Medical Systems

Large investors have recently modified their holdings of the business. Citigroup Inc. acquired a new stake in shares of KORU Medical Systems during the second quarter worth $36,000. California State Teachers Retirement System bought a new stake in shares of KORU Medical Systems in the second quarter valued at approximately $40,000. Tower Research Capital LLC TRC raised its position in shares of KORU Medical Systems by 804.0% in the second quarter. Tower Research Capital LLC TRC now owns 11,779 shares of the company’s stock valued at $41,000 after purchasing an additional 10,476 shares during the period. Prudential Financial Inc. bought a new stake in KORU Medical Systems during the 1st quarter worth approximately $52,000. Finally, Mission Wealth Management LP bought a new stake in KORU Medical Systems during the 3rd quarter worth approximately $34,000. Institutional investors own 58.60% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, B. Riley reissued a “buy” rating and issued a $4.00 price objective on shares of KORU Medical Systems in a research note on Thursday, March 14th.

KORU Medical Systems Company Profile

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.